Table 2.

Summary of enrichment analysis of genes up-regulated in Gsk-3 DKO, p110*, and S33A ESCs.

Name	ID	p-Value	Hit count
GSK-3 DKO ESCs
GO: molecular function
Protein domain specific binding	GO:0019904	1.01 × 10−5	55/633
GO: biological process
Cilium organization	GO:0044782	6.06 × 10−6	19/123
Gene family
CD molecules	CD	5.14 × 10−8	21/276
Tumor necrosis factor receptor superfamily	TNFRSF	5.77 × 10−5	4/12
Intraflagellar transport homologs	IFT	1.52 × 10−4	4/15
Coexpression Atlas
Mendel_RNAseq_e17.5_urothelium		2.74 × 10−16	101/989
Developing lower urinary tract_e13.5		1.04 × 10−13	82/802
P110* ESCs
GO: molecular function
piRNA binding	GO:0034584	3.17 × 10−5	3/3
Gene family
Zinc fingers, C2H2, and BTB domain containing	ZBTB	5.33 × 10−5	6/47
Coexpression Atlas
Mendel_RNAseq_e17.5_urothelium		1.58 × 10−10	65/989
Developing lower urinary tract_e13.5		1.30 × 10−6	30/802
S33A ESCs
GO: molecular function
Organic acid binding	GO:0043177	4.93 × 10−5	26/230
Protein homodimerization activity	GO:0042803	5.15 × 10−5	56/674
Gene family
CD molecules	CD	5.08 × 10−5	18/276

Bonferroni correction method.

All p-Value cutoffs – 0.05.